We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to MAPK1

MAPK1 — MAPK7

Text-mined interactions from Literome

Khan et al., J Biol Chem 2000 : These data demonstrate that incubation of macrophages with alpha1 : SRARKQAASIKVAVSADR, but not intact laminin-1, triggers protein kinase C-dependent activation of MAPK ( erk1/2 ), leading to the up-regulation of proteinase expression
Raggatt et al., J Endocrinol 2000 : CT treatment of cells expressing the insert -ve, but not insert +ve hCTR, induced the phosphorylation of Erk1/2 MAPK , which persisted for at least 72 h. Treatment of cells expressing the insert -ve hCTR with the MAPK kinase ( MEK ) inhibitor, PD-98059, inhibited the phosphorylation of Erk1/2 and abrogated the growth inhibitory effects of salmon CT, the accumulation of cells in G2, and the associated induction of p21 ( WAF1/CIP1 )
Conejo et al., J Cell Physiol 2001 (MAP Kinase Signaling System) : This mitogenic effect of insulin was precluded by inhibition of p70S6-kinase ( either by rapamycin or by the PI3-kinase inhibitor LY294002 ) as well as by inhibition of p44/p42-MAPK with PD098059, but was not affected by inhibition of p38-MAPK
Blaschke et al., Biochem Biophys Res Commun 2002 (Anoxia) : Hypoxia induced a time dependent activation of ERK 1/2 and p38 MAPK activation in human VSMCs, which were completely abolished by PD98059 or SB203580, respectively
Sawamura et al., J Neurochem 2003 (Niemann-Pick Diseases) : In CT43 cells, mitogen activated protein ( MAP ) kinase Erk1/2 was activated and the specific MAPK inhibitor, PD98059, attenuated the hyperphosphorylation of tau
Mathur et al., Nat Med 2004 (MAP Kinase Signaling System) : ERK-1/2 inhibition or IL-10 neutralization restores CD40 induced p38MAPK activation and parasite killing in macrophages and the BALB/c mouse, a susceptible host
Fujii et al., Biochem Biophys Res Commun 2004 (Carcinoma, Hepatocellular...) : CCL20 stimulated growth of HuH7 cells was abrogated by the inhibition of downstream signal transduction pathway mediated by p44/42 MAPK , but not by p38 MAPK or SAPK/JNK
Jiang et al., J Mol Neurosci 2005 (MAP Kinase Signaling System) : A selective MAPK kinase inhibitor, U0126, blocked the H2O2 induced phosphorylation of Erk1/2 ( extracellular signal regulated kinase ) in PC12 cells and increased the levels of active caspase-3 in M-M17-26 under serum withdrawal or H2O2 treatment
Jacquel et al., Oncogene 2006 (Leukemia) : Differentiation of K562 cells by the combination of PMA and SB required Erk1/2 activation, a threshold of JNK activation and p38 MAPK inhibition
Romano et al., Endocrinology 2006 : In the present study, we focused on the involvement of the phosphoinositide 3-kinase (PI3K)/Akt pathway in the MAPK ERK-1/2 regulation and PRL secretion in pituitary cells
Rahman et al., J Immunol 2006 (Asthma...) : IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells : role of MAPK ( Erk1/2 , JNK, and p38 ) pathways
Koch et al., Respir Med 2007 (Asthma) : In conclusion, ( 1 ) p38MAPK-pathway rather than ERK-pathway may play a more basic role in the regulation of the increased T-bet expression in asthma, and ( 2 ) ERK- and p38MAPK-activation modulate IFNgamma expression independently of T-bet and this regulatory role of ERK-1/-2 on IFNgamma release is impaired in asthma
Suzuki et al., J Cell Physiol 2008 (Hemorrhage) : Two hrs thereafter, Kupffer cells and SMPhi production of IL-6, TNF-alpha, and IL-10, activation of MAPK ( p38, ERK-1/2 , and JNK ), and transcription factors ( NF-kappaB and AP-1 ) were determined
Hasan et al., Circ Res 2008 : Inhibiting hemin induced ERK-1/2 activation by U0126 ( MAPK-inhibitor ), the antioxidant N-acetyl cysteine, the NADPH oxidase inhibitors apocynin and diphenyleneiodonium chloride, the superoxide scavenger tiron, or tricarbonyldichlororuthenium ( II ) -dimer ( carbon-monoxide donor ; CORM-2 ) blocked hemin induced Egr-1 expression
Suzuki et al., Cytokine 2008 (Hemorrhage...) : Two hours thereafter, T cell production of IL-2 and IFN-gamma and activation of MAPK ( p38, ERK-1/2 and JNK ) were determined
Matsubayashi et al., J Pathol 2008 (Breast Neoplasms...) : In addition, GRK4-over expressing cells activated the mitogen activated protein kinase ( MAPK ) mediated by ERK 1/2 and JNK phosphorylation in breast cancer derived cell lines
Chandra et al., Clin Exp Immunol 2008 (Leishmaniasis, Visceral...) : Parasites also modulated the TLR2 stimulated mitogen activated protein kinase ( MAPK ) pathway by suppressing MAPK P(38) phosphorylation and activating extracellular regulated kinase (ERK)1/2 phosphorylation
Sheng et al., J Neuroimmune Pharmacol 2009 (MAP Kinase Signaling System) : IL-1beta triggered the activation of p38 and ERK1/2 ( p44/42) MAP kinase (MAPK) signaling pathways, but WIN55,212-2 mainly inhibited p38 MAPK phosphorylation
Kozono et al., Biochem Biophys Res Commun 2010 : CP55940 ( CB1/CB2 agonist ) induced phosphorylation of the extracellular regulated kinases (ERK) 1/2 , p38 mitogen activated protein kinase ( p38MAPK ), and Akt in HGFs. Wound closure by CP55940 in an in-vitro scratch assay was significantly suppressed by inhibitors of MAP kinase kinase ( MEK ), p38MAPK , and phosphoinositol 3-kinase (PI3-K)
McClelland et al., Proc Natl Acad Sci U S A 2010 (MAP Kinase Signaling System) : RNA interference and biochemical experiments support the model that ephrin-B3 regulates synapse density by directly binding to Erk1/2 to inhibit postsynaptic Ras/mitogen activated protein kinase signaling
Bocelli-Tyndall et al., Arthritis Rheum 2010 : Both MAPK/ERK-1/2 and phosphatidylinositol 3-kinase/Akt controlled cell proliferation and HLA-DR expression, but only MAPK/ERK-1/2 controlled the induction of the class II MHC transcription activator protein CIITA, the major determinant of HLA-DR transcription
Jeong et al., J Pharm Pharmacol 2011 (MAP Kinase Signaling System) : Additionally, PD-98058 ( 10 µm ), a selective ERK 1/2 MAPK inhibitor, and SB-203580 ( 10 µm ), a selective p38 MAPK inhibitor , significantly reduced the MIGB induced contraction of ileal longitudinal muscles
Siddhanti et al., Endocrinology 1995 : We found that PMA stimulated DNA synthesis was associated with increments in tyrosine phosphorylation of p44mapk ( ERK1 ) and p42mapk ( ERK2 ) and activation of Raf-1, MKK, and MAPK in these cells ... FSK treatment of osteoblasts, which raised intracellular cAMP levels and inhibited DNA synthesis, blocked PKC stimulated tyrosine phosphorylation of p44mapk ( ERK1 ) and p42mapk ( ERK2 ) as well as inhibited PKC stimulated MAPK and Raf-1 activities
Rose et al., J Immunol 1997 : The selective MAPK/extracellular signal regulated kinase-1 ( MEK-1 ) inhibitor PD 098059 inhibited activation of p42MAPK induced by Fc gamma R cross linking, but not p38 or JNK/SAPK activation
Pyne et al., Biochem J 1997 : This occurs via a pathway that involves : ( 1 ) the protein kinase C ( PKC ) -dependent activation of mitogen activated protein kinase ( MAPK); (2 ) the MAPK dependent phosphorylation and activation of cytosolic phospholipase A2 (cPLA2) and ( 3 ) the utilization of cPLA2 derived arachidonate by the cyclo-oxygenase pathway to produce prostaglandin E2 ( PGE2 )
Kumar et al., J Biol Chem 1998 : These results show that IL-1beta- or TNF induced LDL receptor expression requires ERK-1/2 activation, that the p38 ( MAPK ) pathway negatively regulates LDL receptor expression, and that sterols inhibit induction at a point downstream of ERK-1/2 in HepG2 cells